Tranexamic acid for the management of uterine fibroid tumors: A systematic review of the current evidence.

Abstract

AIM To conduct a detailed systematic review of the current evidence on the administration and efficacy of tranexamic acid in patients with menorrhagia due to uterine fibroids. METHODS We conducted an electronic search on the following databases PubMed and Medline (1950-2013); (1980-2013); Cochrane library (1993-2013). RESULTS A total of 36 articles were retrieved after the initial electronic search. Careful assessment of the retrieved studies led to the final selection of 5 articles for inclusion in the review. CONCLUSION Tranexamic acid may reduce blood loss perioperatively in myomectomies. It may reduce the menorrhagia in patients with fibroids, however a stratification of fibroids by size and location is required to define the responses. It is safe in general, with mild adverse effects observed in some cases. More studies with a double-blind randomized design and larger numbers of participants are necessary to reach more precise and safe conclusions.

DOI: 10.12998/wjcc.v2.i12.893

Cite this paper

@article{Peitsidis2014TranexamicAF, title={Tranexamic acid for the management of uterine fibroid tumors: A systematic review of the current evidence.}, author={Panagiotis Peitsidis and Anna Koukoulomati}, journal={World journal of clinical cases}, year={2014}, volume={2 12}, pages={893-8} }